On April 10, 2026, the Presidency of the Center for Technological Development and Innovation E.P.E. (CDTI) approved the 2026 Call for the NEOTEC program, with a maximum total amount of 20.38 M€ aimed at innovative technology-based companies. Additionally, within the available budget, a minimum amount of 5 M€ will be reserved for women-led companies.

The objective of this call is to promote technology and innovation as competitive factors for business development. The call will finance new business projects emerging from small companies that require the use of technologies or knowledge developed from research activity and where the business strategy is based on the development of their own technology. 

  • Grants: subsidies of up to 70% of the project budget / 85% if the proposal includes hiring doctors.
  • Minimum fundable budget: 175,000 euros.
  • Maximum subsidy: 250,000 euros per beneficiary / 325,000€ if the proposal includes hiring doctors.
  • Deadlines: starts on April 14, 2026 and ends on May 14, 2026, at 12:00 hours.

Following the publication of the new call and, given its importance and the interest generated in the sector, BIOVEGEN has prepared a report summarizing the main characteristics of the NEOTEC 2026 Call.